Analyst Information for Leap Therapeutics Inc.

$ 1.935   -0.075 (-3.73%) Volume: 388.43k 3:19 PM EDT 10-Jul-2020
Consensus Rating Average
Consensus Rating for LPTX is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.20
Previous Average Recommendation 1.25
Change in Average Recommendation -0.05
Number of Analysts Reporting 5
Strong Buy
1.0
Current: 1.20
Previous: 1.25
Change: -0.05
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 395
Rank Recommendation relative to companies in its industry 217
Ranked 217 in Industry
1395 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 4
Analysts recommending Moderate Buy 1
Analysts recommending Hold 0
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 3 3
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.20 1.25 1.25 1.25

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.